autoimmune disease

Pfizer tops pharma reputation rankings from autoimmune patients
Medical Marketing and Media
Mon, 11/7/22 - 05:21 pm
Pfizer
autoimmune disease
reputation
Autoimmune drug biotech HI-Bio unveils $120M to root out cellular drivers of disease
MedCity News
Tue, 11/1/22 - 10:55 am
Human Immunology Bioscience
autoimmune disease
R&D
MorphoSys
kidney disease
AbbVie sheds autoimmune disease drug in blow to partner Inventiva
Pharmaphorum
Mon, 10/31/22 - 10:21 am
AbbVie
autoimmune disease
Inventiva
cedirogant
Pfizer, Merck and J&J Back UK Startup Mining the Dark Genome for Autoimmune Therapies
BioSpace
Wed, 10/19/22 - 10:44 am
Nucleome Therapeutics
funding
precision medicine
autoimmune diseases
Pfizer
JNJ
Merck KGaA
autoimmune disease
Covalent drugs take the stage — again — in Atlas Venture’s latest startup
BioPharma Dive
Sun, 10/16/22 - 05:24 pm
Matchpoint Therapeutics
Atlas Venture
Access Biotechnology
covalent drugs
autoimmune disease
BMS was first but startup Sudo Bio aims to be best at blocking key autoimmune target
MedCity News
Sun, 10/2/22 - 07:38 pm
Sudo Bioscience
TYK2 inhibitors
autoimmune disease
funding
Bristol Myers Squibb
Gilead completes acquisition of MiroBio in $405m cash deal
PM Live
Wed, 09/21/22 - 10:29 am
Gilead Sciences
M&A
MiroBio
autoimmune disease
‘Treg’ cell therapy: bringing CAR-T to autoimmune disease
BioPharma Dive
Tue, 08/16/22 - 10:52 am
Treg cell therapy
autoimmune disease
Kyverna Therapeutics
Quell Therapeutics
Sonoma Biotherapeutics
GentiBio
Abata Therapeutics
Trio of biotechs raise funds to make enzymes and develop drugs for IBS and other autoimmune diseases
Endpoints
Fri, 07/8/22 - 10:56 am
Hulli Bio
funding
IBS
Precision Autoimmune Therapeutics
autoimmune disease
Zhiyi Biotech
Chasing AnaptysBio and Lilly, MiroBio rounds up $97M for autoimmune checkpoint agonist clinical trials
Fierce Biotech
Wed, 06/29/22 - 10:51 am
MiroBio
venture capital
autoimmune disease
Eli Lilly
AnaptysBio
Medicxi
OrbiMed
More drug, fewer jabs: Novartis' Sandoz eyes EMA nod for high-concentration Humira copy
Fierce Pharma
Mon, 06/20/22 - 10:37 am
Novartis
Sandoz
AbbVie
Humira
Europe
biosimilars
autoimmune disease
EMA
Hyrimoz
Thermo Fisher's (TMO) Autoimmune Disease Test Gets FDA Nod
Yahoo/Zacks.com
Fri, 06/10/22 - 10:39 am
FDA
Thermo Fisher Scientific
diagnostics
Medtech
autoimmune disease
EliA RNA Polymerase III
EliA Rib-P
systemic sclerosis
systemic lupus erythematosus
AbbVie and Cugene Announce Collaboration in Autoimmune Diseases
BioSpace
Mon, 05/16/22 - 10:28 am
AbbVie
Cugene
CUG252
Treg cell therapy
autoimmune disease
Amgen spinout Kezar hits PhII hurdle, all eyes on June readout for drug’s other study
Endpoints
Wed, 05/4/22 - 10:39 am
Amgen
Kezar Life Sciences
zetomipzomib
autoimmune disease
dermatomyositis
polymyositis
Backed by $100M, Star Therapeutics sets out to find constellations of rare disease
MedCity News
Wed, 02/16/22 - 10:43 am
Star Therapeutics
Electra Therapeutics
autoimmune disease
Rare Diseases
sHLH
Xencor finally finds buyer for onetime lead drug, offloading autoimmune asset to Tesaro co-founder in backloaded deal
Fierce Biotech
Mon, 11/22/21 - 10:37 am
Xencor
obexelimab
Zenas BioPharma
autoimmune disease
PlateletBio announces $75.5M Series B to extend autoimmune cell therapy
Endpoints
Thu, 11/4/21 - 10:22 am
PlateletBio
funding
autoimmune disease
cell therapy
Ventyx nabs a $152M upsized IPO to challenge BMS' Zeposia—and a backer with intimate knowledge of its rival
Fierce Biotech
Fri, 10/22/21 - 12:04 pm
Ventyx Biosciences
IPOs
autoimmune disease
Bristol Myers Squibb
Zeposia
NIH launches study into COVID-19 vaccine booster among people with autoimmune disease
Biopharma Reporter
Wed, 09/1/21 - 11:04 am
NIH
autoimmune disease
clinical trials
COVID-19
vaccines
boosters
Eight Months After First FDA Approval, Aurinia Picks Up Two More Candidates
BioSpace
Tue, 08/17/21 - 10:40 pm
Aurinia Pharmaceuticals
autoimmune disease
Thunderbolt Pharma
M&A

Pages